echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > European Radiology: Are you still having a headache differentiating adrenal pheochromocytoma from lipodeficiency adenoma?

    European Radiology: Are you still having a headache differentiating adrenal pheochromocytoma from lipodeficiency adenoma?

    • Last Update: 2022-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to statistics, about 5% of patients detect accidental adrenal nodules
    on imaging.
    Adrenal metastases can be
    reasonably excluded by the presence or absence of a personal history of primary malignancy, and adrenal cortical carcinoma (ACC) is extremely rare, radiographically aggressive, and usually > 4 cm
    in diameter.
    Among
    routine diagnostic considerations, benign adrenal tumors are the most common, followed by pheochromocytomas
    .
    Symptomatic pheochromocytoma can be
    diagnosed clinically; However, pheochromocytoma can be asymptomatic
    in 5-58% of cases.

    Biochemical testing of incidental adrenal nodules is clinically recommended, and pheochromocytoma has been reported to be diagnosed with greater than 90%
    accuracy.
    Imaging remains necessary in patients with established pheochromocytoma
    for localization and surgical planning, especially in patients with multiple nodules
    .
    In patients with known or suspected concurrent pheochromocytoma,
    imaging is necessary to screen for further development of pheochromocytoma and paraganglioma.

    However, differentiating between pheochromocytoma and adenoma with CT or MRI is a challenge
    .
    On CT
    scan, there is some overlap in the imaging features of pheochromocytoma and adenoma.

    MRI is also limited in the diagnosis of pheochromocytoma, with approximately 30% of pheochromocytomas absent from the characteristic "bulb-like
    " T2-weighted (T2W) hyperintensity
    .
    Recent studies have explored the use of texture analysis or machine learning for radiological features to diagnose pheochromocytoma
    .
    However, these studies, which applied different radiological analyses to different imaging studies, showed results that lacked validation and were not easily applied to clinical practice
    .

    A study published in the journal European Radiology evaluated the diagnostic accuracy and reproducibility of adrenal T2WI MRI in distinguishing metastases from adrenal adenomas
    in populations with pheochromocytoma and lipodeficiency adenoma.

    This study compared 29 consecutive pheochromocytomas resected between 2010 and 2019 with 23 continuous fat-depleting adrenal tumors.

    Three
    radiologists (R1, R2, R3) subjectively assessed T2W signal intensity and heterogeneity and extracted T2W signal intensity ratio (SIR) and entropy
    .
    These values were grouped into the quantitative and qualitative T2WI adrenal MRI calculator (logistic regression models containing T2W SIR+ entropy and subjective SI [relative to the renal cortex] and heterogeneity), using predefined thresholds to distinguish metastases from adenomas, and using 2×2 table analysis for accuracy
    .

    Subjectively, all three radiologists agreed that pheochromocytoma was brighter (P < 0.
    001) and more heterogeneous (P < 0.
    001).

    Observer-to-observer agreement was fair to moderate (K = 0.
    37-0.
    46) and moderate in terms of heterogeneity (K = 0.
    24-0.
    32)
    in terms of T2W signal intensity.
    The T2W-SI ratio (P<0.
    001) and entropy (P<0.
    001) were both higher
    than those of pheochromocytoma in all three readers.
    The sensitivity, specificity, and accuracy of the quantitative calculator in distinguishing between pheochromocytoma and adenoma were high (100% [95% confidence interval 88–100%], 87% [66–97%], and 94% [86–100%] R1; 93% [77-99%], 96% [78-100%] and 94% [88-100%] R2; 97% [82-100%], 96% [78-100%], and 96% [91-100%] R3).

    Qualitative calculators have
    high specificity, but low sensitivity and overall accuracy (48% [29-68%], 100% [85-100%], and 74% [65-83%]R1; 45% [26-64%], 100% [85-100%], and 72% [63-82%]R2; 59% [39-77%], 100% [85-100%], and 79% [70-88%R3)).


    Figure A
    48-year-old male patient with 2.
    3 cm of fat-fatigued adrenal tumor is diagnosed
    by 2 years of stable imaging (not shown) and negative biochemistry.
    Axial T2-weighted (T2W) HASTE image, adenoma (arrow) rated by three radiologists as a homogeneous mass, low intensity (not shown) relative to the renal cortex parenchyma

    This study suggests that pheochromocytoma assessed by subjective and quantitative assessment has higher T2-weighted signal intensity and heterogeneity
    compared with fat-depleted adrenal tumors.
    Using existing T2W adrenal MRI evaluation models, high sensitivity, specificity, and overall accuracy
    in the diagnosis of pheochromocytoma were achieved through quantitative T2W signal intensity ratio and entropy.

     

    Original source:

    Rosalind Gerson,Wendy Tu,Jorge Abreu-Gomez,et al.
    Evaluation of the T2-weighted (T2W) adrenal MRI calculator to differentiate adrenal pheochromocytoma from lipid-poor adrenal adenoma.
    DOI:10.
    1007/s00330-022-08867-4

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.